➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Mallinckrodt
McKesson
Baxter
AstraZeneca

Last Updated: April 21, 2021

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Abhai, LLC (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Purdue Pharma L.P. v. Abhai, LLC (D. Del. 2016)

Docket   Start Trial Date Filed 2016-01-18
Court District Court, D. Delaware Date Terminated 2017-12-27
Cause 35:145 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To Sherry R. Fallon
Parties PURDUE PHARMACEUTICALS L.P.
Patents 7,674,799; 7,674,800; 7,683,072; 8,114,383; 8,309,060; 8,337,888; 8,808,741; 8,894,987; 8,894,988; 9,060,976; 9,073,933
Attorneys Jack B. Blumenfeld
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Abhai, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Purdue Pharma L.P. v. Abhai, LLC (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-01-18 1 United States Patent Nos. 7,674,799 (“the ’799 patent”); 7,674,800 (“the ’800 patent”); 7,683,072 (“…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 7,674,799) 75. Purdue…(“the ’072 patent”); 8,114,383 (“the ’383 patent”); 8,309,060 (“the ’060 patent”); 8,337,888 (“the ’888…’888 patent”); 8,808,741 (“the ’741 patent”); 8,894,987 (“the ’987 patent”); 8,894,988 (“the ’988 patent9,060,976 (“the ’976 patent”); and 9,073,933 (“the ’933 patent”) (collectively, “the patents-in- suit”). External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Harvard Business School
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.